Skip to main content

Table 1 Clinicopathological features of patients with recurrent adenocarcinoma of the lung

From: Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

Total n = 237

 

Mean age, year (range)

66.3 (38–86)

Male, (%)

133 (56.1%)

Surgical procedure, (%)

 pneumonectomy

5 (2.1%)

 lobectomy

228 (96.2%)

 segmentectomy

4 (1.7%)

Pathological stage, (%)

 I

60 (25.3%)

 II

62 (26.2%)

 III

115 (48.5%)

Recurrence pattern, (%)

 locoregional

72 (30.4%)

 systemic

165 (69.6%)

EGFR status, (%)

 mutant

108 (45.6%)

 exon 18

5 (2.1%)

 exon 19

56 (23.6%)

 exon 20

1 (0.4%)

 exon 21

46 (19.4%)

 wild-type

129 (54.4%)

  1. EGFR, epidermal growth factor receptor